To further ascertain whether the enhanced T-cell activity after naringenin treatment facilitates its inhibitory effect on breast cancer pulmonary metastasis, we transferred the T cells from 4T1/TGF-β1 tumor-bearing mice into nude mice along with 4T1/TGF-β1 tumor cells. The gene discussed is TGFB1; the disease is neoplasm.